Company registration number 07974371 (England and Wales)
DSM PHARMA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
DSM PHARMA LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 5
DSM PHARMA LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
1,592,333
1,800,583
Tangible assets
4
1,193,440
1,191,967
2,785,773
2,992,550
Current assets
Stocks
73,508
65,793
Debtors
5
411,823
299,297
Cash at bank and in hand
398
25,327
485,729
390,417
Creditors: amounts falling due within one year
6
(997,021)
(1,192,279)
Net current liabilities
(511,292)
(801,862)
Total assets less current liabilities
2,274,481
2,190,688
Creditors: amounts falling due after more than one year
7
(1,931,873)
(2,030,598)
Net assets
342,608
160,090
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
342,508
159,990
Total equity
342,608
160,090
DSM PHARMA LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 12 March 2026
Mrs Deepa Morar
Director
Company registration number 07974371 (England and Wales)
DSM PHARMA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

DSM Pharma Limited is a private company limited by shares incorporated in England and Wales. The registered office is 134 Buckingham Palace Road, London, SW1W 9SA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

1.3
Intangible fixed assets - goodwill

Acquired goodwill is written off in equal annual installments over its estimated useful economic life.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Freehold
Fixtures, fittings & equipment
20% Straight Line basis
Computer equipment
20% Straight Line basis.
1.5
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
10
10
DSM PHARMA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2024 and 31 March 2025
2,557,500
Amortisation and impairment
At 1 April 2024
756,917
Amortisation charged for the year
208,250
At 31 March 2025
965,167
Carrying amount
At 31 March 2025
1,592,333
At 31 March 2024
1,800,583
4
Tangible fixed assets
Land and buildings Freehold
Fixtures, fittings & equipment
Computer equipment
Total
£
£
£
£
Cost
At 1 April 2024
1,183,788
100,668
10,958
1,295,414
Additions
-
0
3,014
1,520
4,534
At 31 March 2025
1,183,788
103,682
12,478
1,299,948
Depreciation and impairment
At 1 April 2024
-
0
99,509
3,939
103,447
Depreciation charged in the year
-
0
654
2,406
3,060
At 31 March 2025
-
0
100,163
6,345
106,508
Carrying amount
At 31 March 2025
1,183,788
3,519
6,133
1,193,440
At 31 March 2024
1,183,788
1,159
7,020
1,191,967
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
356,983
238,733
Other debtors
50,692
56,416
Prepayments and accrued income
4,148
4,148
411,823
299,297
DSM PHARMA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
45,776
-
0
Trade creditors
390,834
408,230
Corporation tax
82,308
30,000
Other taxation and social security
48,473
23,396
Other creditors
422,130
708,153
Accruals and deferred income
7,500
22,500
997,021
1,192,279
7
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
1,931,873
2,030,598
2025-03-31 2024-04-01 false false false CCH Software CCH Accounts Production 2025.200 No description of principal activity Mrs Deepa Morar Mr Sundip Morar 07974371 2024-04-01 2025-03-31 07974371 2025-03-31 07974371 2024-03-31 07974371 core:NetGoodwill 2025-03-31 07974371 core:NetGoodwill 2024-03-31 07974371 core:LandBuildings core:OwnedOrFreeholdAssets 2025-03-31 07974371 core:FurnitureFittings 2025-03-31 07974371 core:ComputerEquipment 2025-03-31 07974371 core:LandBuildings core:OwnedOrFreeholdAssets 2024-03-31 07974371 core:FurnitureFittings 2024-03-31 07974371 core:ComputerEquipment 2024-03-31 07974371 core:ShareCapital 2025-03-31 07974371 core:ShareCapital 2024-03-31 07974371 core:RetainedEarningsAccumulatedLosses 2025-03-31 07974371 core:RetainedEarningsAccumulatedLosses 2024-03-31 07974371 bus:Director1 2024-04-01 2025-03-31 07974371 core:Goodwill 2024-04-01 2025-03-31 07974371 core:FurnitureFittings 2024-04-01 2025-03-31 07974371 core:ComputerEquipment 2024-04-01 2025-03-31 07974371 2023-04-01 2024-03-31 07974371 core:NetGoodwill 2024-03-31 07974371 core:NetGoodwill 2024-04-01 2025-03-31 07974371 core:LandBuildings core:OwnedOrFreeholdAssets 2024-03-31 07974371 core:FurnitureFittings 2024-03-31 07974371 core:ComputerEquipment 2024-03-31 07974371 2024-03-31 07974371 core:LandBuildings core:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 07974371 core:CurrentFinancialInstruments 2025-03-31 07974371 core:CurrentFinancialInstruments 2024-03-31 07974371 core:Non-currentFinancialInstruments 2025-03-31 07974371 core:Non-currentFinancialInstruments 2024-03-31 07974371 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07974371 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07974371 bus:FRS102 2024-04-01 2025-03-31 07974371 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 07974371 bus:CompanySecretary1 2024-04-01 2025-03-31 07974371 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP